Pharma and Life Sciences Impact Survey
Posted on: March 17th 2021 · read
In 2021 the Life Sciences, Pharma and MedTech sector continues to face many challenges, buffeted both by Covid-19 and Brexit. The pandemic has brought healthcare at the forefront of public debate, which can be a positive factor, but Brexit presents a number of regulatory hurdles and challenges for this and other sectors.
We are keen to hear your views on the impact of the pandemic and Brexit on various parts of your business. We have put together some questions to ‘take the temperature’ at this moment in time. We’d appreciate if you could spare a few minutes to complete this survey, which shouldn’t take longer than 3 minutes.
All responses will remain anonymous and we will publish our findings on MHA-UK in May 2021.